Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-29 @ 9:39 PM
Study NCT ID:
NCT07013851
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-10
First Post:
2025-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
Sponsor:
Grupo Español de Investigación en Cáncer de Ovario
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-28
First Submit QC Date:
None
Study First Post Date:
2025-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-06
Last Update Post Date:
2025-06-10
Last Update Post Date Type:
ACTUAL